Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53/mTOR pathway
Open Access
- 30 September 2022
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 20 (1) , 1-17
Abstract
Background: Gallbladder cancer (GBC) is a highly aggressive malignant cancer in the biliary system with poor prognosis. XPO1 (chromosome region maintenance 1 or CRM1) mediates the nuclear export of several proteins, mainly tumor suppressors. Thus, XPO1 functions as a pro-oncogenic factor. KPT-330 (Selinexor) is a United States Food and Drug Administration approved selective inhibitor of XPO1 that demonstrates good therapeutic effects in hematologic cancers. However, the function of XPO1 and the effect of KPT-330 have not been reported in GBC. Methods: We analyzed the correlation between XPO1 expression levels by q-PCR and clinical features of GBC patients. Cell proliferation assays were used to analyze the in vitro antitumor effects of XPO1 inhibitor KPT-330. mRNA sequencing was used to explore the underlying mechanisms. Western blot was performed to explore the relationship between apoptosis and autophagy. The in vivo antitumor effect of KPT-330 was investigated in a nude mouse model of gallbladder cancer. Results: We found that high expression of XPO1 was related to poor prognosis of GBC patients. We observed that XPO1 inhibitor KPT-330 inhibited the proliferation of GBC cells in vitro. Furthermore, XPO1 inhibitor KPT-330 induced apoptosis by reducing the mitochondrial membrane potential and triggering autophagy in NOZ and GBC-SD cells. Indeed, XPO1 inhibitor KPT-330 led to nuclear accumulation of p53 and activated the p53/mTOR pathway to regulate autophagy-dependent apoptosis. Importantly, KPT-330 suppressed tumor growth with no obvious toxic effects in vivo. Conclusion: XPO1 may be a promising prognostic indicator for GBC, and KPT-330 appears to be a potential drug for treating GBC effectively and safely.Keywords
Funding Information
- National Natural Science Foundation of China (82172628, 81974371, 31701108, 82002503, 82173081)
This publication has 47 references indexed in Scilit:
- Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damageAutophagy, 2012
- Gallbladder cancer: Can newer insights improve the outcome?Journal of Gastroenterology and Hepatology, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Current Management of Gallbladder CarcinomaThe Oncologist, 2010
- The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variantsNucleic Acids Research, 2009
- Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 InhibitionCancer Research, 2009
- Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphomaLeukemia, 2009
- Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: Structure–activity relationship and mechanism of actionBioorganic & Medicinal Chemistry, 2008
- KEGG for linking genomes to life and the environmentNucleic Acids Research, 2007
- BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin BBlood, 2006